Merck | MRK - Ebitda



Merck reported EUR1.46B in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Adidas EUR 809M 83M Jun/2025
Adyen EUR 563.42M 142.82M Dec/2024
Akzo Nobel EUR 393M 35M Jun/2025
Alcon AG USD 250M 213M Jun/2025
Amadeus IT EUR 647.7M 19.4M Jun/2025
Amarin USD -16025000 714K Mar/2025
AstraZeneca USD 4.96B 127M Jun/2025
BASF EUR 1.77B 1.2B Jun/2025
Bayer EUR 236M 3.35B Jun/2025
Beiersdorf EUR 837M 163M Dec/2024
Covestro EUR 266M 129M Jun/2025
Danone EUR 2.45B 149M Jun/2025
Fresenius EUR 828M 88M Jun/2025
Fresenius Medical Care EUR 871M 282M Jun/2025
Galapagos EUR -158708000 177.84M Mar/2025
Genmab DKK 376M 172M Jun/2025
Givaudan CHF 910M 196M Jun/2024
GlaxoSmithKline GBP 3.18B 45M Jun/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Henkel EUR 1.88B 139M Dec/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Infineon EUR 909M 37M Jun/2025
Linde USD 3.36B 35M Jun/2025
Lonza CHF 1.01B 139M Dec/2024
Merck EUR 1.46B 45M Jun/2025
Novartis USD 6.17B 339M Jun/2025
Philips EUR 747M 174M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 1.89B 971M Jun/2025
UCB EUR 1.37B 715M Dec/2024